+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Siemens Healthineers AG (SHL) - Financial and Strategic SWOT Analysis Review

Siemens Healthineers AG (SHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Siemens Healthineers AG (Siemens Healthineers), a subsidiary of Siemens AG, is a medical technology company that designs, develops, produces, and distributes diagnostic imaging systems, clinical and workflow systems and solutions, and systems for minimally invasive procedures. The company’s major products include molecular imaging systems, X-ray products, ultrasound systems, computed tomography systems, magnetic resonance imaging systems, testing systems, point-of-care (POC) testing systems, mobile C-arms, hybrid ORs, and angiography systems. It also offers enterprise and digital services. Siemens Healthineers serves healthcare providers including laboratories, clinics, hospitals, hospital systems, physicians, public health agencies, universities, state-run and private health insurers, pharmaceutical companies, and clinical research institutes. The company operates in Europe, the Americas, the Middle East, Africa, and Asia-Pacific. Siemens Healthineers is headquartered in Erlangen, Germany.

Siemens Healthineers AG Key Recent Developments

  • Apr 02, 2024: Siemens Healthineers Integrates Hemostasis Product Offerings in United States and Europe
  • Apr 02, 2024: Sysmex America Begins Selling Hemostasis Instruments and Reagents Under the Sysmex Brand in the United States
  • Mar 21, 2024: Siemens Healthineers Has Developed an Automated, Self-Driving C-Arm System for Intraoperative Imaging in Surgery
  • Mar 18, 2024: Siemens Healthineers Intends to Close Fast Track Diagnostics

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Siemens Healthineers AG - Key Facts
  • Siemens Healthineers AG - Key Employees
  • Siemens Healthineers AG - Key Employee Biographies
  • Siemens Healthineers AG - Major Products and Services
  • Siemens Healthineers AG - History
  • Siemens Healthineers AG - Company Statement
  • Siemens Healthineers AG - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Affiliate
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Siemens Healthineers AG - Business Description
  • Business Segment: Advanced Therapies
  • Overview
  • Performance
  • Business Segment: Diagnostics
  • Overview
  • Performance
  • Business Segment: Imaging
  • Overview
  • Performance
  • Business Segment: Varian
  • Overview
  • Performance
  • Geographical Segment: Americas
  • Performance
  • Geographical Segment: Asia Pacific Japan
  • Performance
  • Geographical Segment: China
  • Performance
  • Geographical Segment: Europe, C. I. S., Africa, Middle East (EMEA)
  • Performance
  • R&D Overview
  • Siemens Healthineers AG - Corporate Strategy
  • Siemens Healthineers AG - SWOT Analysis
  • SWOT Analysis - Overview
  • Siemens Healthineers AG - Strengths
  • Siemens Healthineers AG - Weaknesses
  • Siemens Healthineers AG - Opportunities
  • Siemens Healthineers AG - Threats
  • Siemens Healthineers AG - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Siemens Healthineers AG, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Siemens Healthineers AG, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Siemens Healthineers AG, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 02, 2024: Siemens Healthineers Integrates Hemostasis Product Offerings in United States and Europe
  • Apr 02, 2024: Sysmex America Begins Selling Hemostasis Instruments and Reagents Under the Sysmex Brand in the United States
  • Mar 21, 2024: Siemens Healthineers Has Developed an Automated, Self-Driving C-Arm System for Intraoperative Imaging in Surgery
  • Mar 18, 2024: Siemens Healthineers Intends to Close Fast Track Diagnostics
  • Mar 01, 2024: Smartalpha Partners With Siemens Healthineers to Advance AI-Powered Workflow Efficiencies in Ultrasound
  • Feb 01, 2024: Siemens Healthineers Lays Solid Foundation for Fiscal Year 2024 with Strong Growth in First Quarter
  • Jan 24, 2024: Siemens Healthineers and IISc Launch Laboratory for AI in Precision Medicine to Revolutionise Neurology Research
  • Dec 05, 2023: OU Health Partners with Siemens Healthineers to Improve Health in Oklahoma, Promote Research, Innovation
  • Nov 26, 2023: Siemens Healthineers Shows Potential of Generative AI in Medical Technology
  • Nov 20, 2023: Siemens Healthineers Contracts with US NIH to Aid Rapid Pathogen Detection and Guide Antibiotic Treatment for Sepsis
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Siemens Healthineers AG, Key Facts
  • Siemens Healthineers AG, Key Employees
  • Siemens Healthineers AG, Key Employee Biographies
  • Siemens Healthineers AG, Major Products and Services
  • Siemens Healthineers AG, History
  • Siemens Healthineers AG, Other Locations
  • Siemens Healthineers AG, Subsidiaries
  • Siemens Healthineers AG, Affiliate
  • Siemens Healthineers AG, Joint Venture
  • Siemens Healthineers AG, Key Competitors
  • Siemens Healthineers AG, Ratios based on current share price
  • Siemens Healthineers AG, Annual Ratios
  • Siemens Healthineers AG, Annual Ratios (Cont...1)
  • Siemens Healthineers AG, Annual Ratios (Cont...2)
  • Siemens Healthineers AG, Interim Ratios
  • Siemens Healthineers AG, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Siemens Healthineers AG, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Siemens Healthineers AG, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Siemens Healthineers AG, Performance Chart (2019 - 2023)
  • Siemens Healthineers AG, Ratio Charts
  • Siemens Healthineers AG, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Siemens Healthineers AG, Medical Equipment, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Hologic Inc
  • Elekta AB
  • Abbott Laboratories
  • Star Equity Holdings Inc
  • McKesson Corp
  • Star Equity Holdings Inc
  • Abbott Laboratories
  • Hologic Inc
  • Elekta AB
  • McKesson Corp
  • F. Hoffmann-La Roche Ltd